1. Home
  2. SHIP vs NGNE Comparison

SHIP vs NGNE Comparison

Compare SHIP & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$11.97

Market Cap

281.9M

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$20.31

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIP
NGNE
Founded
2008
2003
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.9M
327.8M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
SHIP
NGNE
Price
$11.97
$20.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$17.00
$60.13
AVG Volume (30 Days)
273.3K
187.4K
Earning Date
02-17-2026
03-24-2026
Dividend Yield
3.47%
N/A
EPS Growth
N/A
0.93
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.79
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.79
$6.88
52 Week High
$14.93
$37.27

Technical Indicators

Market Signals
Indicator
SHIP
NGNE
Relative Strength Index (RSI) 43.07 48.80
Support Level $7.85 $19.03
Resistance Level $14.93 $21.03
Average True Range (ATR) 0.63 1.61
MACD -0.18 -0.17
Stochastic Oscillator 5.45 37.28

Price Performance

Historical Comparison
SHIP
NGNE

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: